Novo Nordisk sells the weight loss drug under three different brands: Ozempic injection and Rybelsus tablets for type 2 diabetes, and Wegovy injection for chronic weight management
Its symptoms include tremors, rigidity, bradykinesia (slowness of movement), and postural instability
Meanwhile, GLP-1 medications, once niche, have gained widespread attention for weight management and metabolic health
(D) Diverse payload classes, encompassing microtubule inhibitors (e.g., auristatins, maytansinoids), DNA-damaging agents (e.g., calicheamicin, duocarmycins, PBDs), topoisomerase I inhibitors (e.g., DXd, SN-38), and other emerging payloads (e.g., RNA polymerase II inhibitors such as amanitins)